Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ARNA 4.49 +0.05 (1.13%)
price chart
Arena Pharmaceuticals Inc.'s Plan to Win the Obesity Drug War
Considering the number of obese Americans -- 35% of the entire U.S. adult population, according to the Centers for Disease Control and Prevention -- obesity-drug makers haven't come close to reaching their potential.
Arena: Belviq Scripts Pop, Recover From Previous Dip
Arena Pharmaceuticals (NASDAQ:ARNA) investors had something to smile about when script numbers for the week ending April 17th were released today.
Don't Write Off Arena As Yet
All the company said was that "a lesser amount of Arena's total 2015 revenues will consist of regulatory milestones.
Traders Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Alexion ...
Eisai Inc. and Arena Pharmaceuticals, Inc. (ARNA) on Apr. 10 announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of ...
Healthcare Sector Movers: Akorn, Inc. (AKRX), Alexion Pharmaceuticals, Inc ...  WallStreet Scope
Arena Pharmaceuticals (ARNA) Stock Gains Today on New Patent Approval
"We rate ARENA PHARMACEUTICALS INC (ARNA) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared ...
Arena Pharmaceuticals shares rise on weight loss drug patent  San Francisco Chronicle
Arena Pharmaceuticals Up on Belviqs New Patent Approval  Zacks.com
The Insider, Randall Woods Unloaded 76268 Shares of Arena Pharmaceuticals ...
76,268 shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) were unloaded by Randall Woods, the corporation's director.
Arena Pharmaceuticals Director Randall E. Woods Sells 76268 Shares (ARNA)  The Legacy
Insider Selling: Randall E. Woods Sells 76268 Shares of Arena ...  sleekmoney
Insider Selling: Facebook Inc (FB), Salesforce.Com, Inc. (CRM), Arena ...
Bidness Etc updates its readers on recent insider selling activity that happened at Facebook Inc (NASDAQ:FB), Salesforce.com, Inc. (NYSE:CRM), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), and Aetna Inc (NYSE:AET).
Arena's 15000 Scripts Set Pace Vs. Competitors
Disclosure: The author is long ARNA, OREX. (More...)The author wrote this article themselves, and it expresses their own opinions.
Well, Whaddya Know? Arena Pharmaceuticals is On the Verge. (ARNA, VVUS ...  SmallCap Network
Hot and Soars Stocks: Apache Corp. (NYSE:APA), Arena Pharmaceuticals, Inc ...  eMarketsDaily
Arena secures new Belviq patent; Eisai cuts sales force (ARNA)
... consisting of 90 sales representatives that will promote BELVIQ and two other Eisai products and a shared contract field force of 230 representatives to promote BELVIQ on behalf of Eisai and another product on behalf of another pharmaceutical ...
Eisai, Arena Pharma (ARNA) Announce Completion of Lorcaserin XR ...  StreetInsider.com
Arena Pharmaceuticals, Eisai complete trials of weight-management drug  San Diego Source (subscription)
Arena - Assessing Belviq In South Korea (ARNA)
Arena Pharmaceuticals (NASDAQ:ARNA) partnered with Ildong in South Korea for Belviq. Belviq received approval in that nation earlier this year and launched in late February.